Rare Disease Groups, Pharmas Join SMA Europe Push for Newborn Screening

SMA News Today’s multimedia associate, Price Wooldridge, discusses rare disease groups and pharmaceutical companies, joining SMA Europe in a push for newborn screening for Spinal Muscular Atrophy (SMA).

Forums Director Kevin Schaefer shares his thoughts on “Disability Visibility,” a collection of first-person essays from a wide range of disabled authors.

Are you interested in learning more about spinal muscular atrophy? If so, please visit https://smanewstoday.com/